Interventional Oncology Devices Market Global Trend, Demand, Scope, Growth Analysis and Industry Forecast 2020 -2027

The report relies on advanced primary and secondary research methodologies to assess information. The data for the study is gathered from reliable and trustworthy sources, ensuring the authenticity and accuracy of the research study. We also employ qualitative and quantitative analysis to deliver a comprehensive and all-encompassing research study on the global Interventional Oncology Devices market. The report also comprises of SWOT analysis, PESTLE analysis, and Porter’s Five Forces Model analysis,  to offer the reader with a complete and all-inclusive study of crucial segments of the global Interventional Oncology Devices market. The global Interventional Oncology Devices Market is forecasted to be worth USD 3.11 Billion by 2027, according to a current analysis by Emergen Research.

Key Highlights From The Report

In September 2020, The strategic investment in Nanospectra Biosciences, Inc. was announced by Sirtex Medical Limited. The investment will offer funding to improve further Nanospectra 's leading prostate cancer tissue ablation device AuroLase, the first and only ultra-focal ablation treatment intended to enhance the efficiency of treatment, reducing adverse effects related to anesthesia, chemotherapy, and alternate focal therapies. In order to destroy solid cancer tumors, this treatment uses the company's patented AuroShells nanoparticle technique to minimize the damage of neighboring healthy tissue.

Over the forecasted timeline, the Embolization segment accounted for the largest market with a CAGR of 6.7%, since it is a minimally invasive therapy that offers advantages such as quick recovery, can be practiced through local anesthesia, and cost-effective.

It is anticipated that Bland Embolization or Transcatheter Arterial Embolization will expand significantly. This method is being used for the treatment of liver tumors or for postsurgical adjunctive treatment.

The segment of lung cancer will dominate the market during the forecasted period since smoking habits have increased the incidence of lung cancer.

Due to the rising prevalence of cancer, easy availability of interventional oncology, and the fast adoption of technological advancement owing to significant government spending on medical treatment, the North American region is expected to dominate the market.

Key participants include Sirtex Medical Limited, Teleflex Incorporated, Boston Scientific Corporation, INterface BIOmaterials B.V., Merit Medical Systems, Inc., BTG International Limited, IMBiotechnologies Ltd., IceCure Medical Ltd, HealthTronics, Inc., and Cook Medical Inc., among others.

You Can Download Free Sample PDF Copy of Interventional Oncology Devices Market at https://www.emergenresearch.com/request-sample/387

Product Type Outlook (Revenue, USD Billion; 2017-2027)

Support

Embolization

Ablation

Process Outlook (Revenue, USD Billion; 2017-2027)

Non-Thermal Tumor Ablation

Thermal Tumor Ablation

Transcatheter Arterial Radioembolization

Transcatheter Arterial Chemoembolization

Bland Embolization or Transcatheter Arterial Embolization

Cancer Type Outlook (Revenue, USD Billion; 2017-2027)

Lung Cancer

Liver Cancer

Bone Cancer

Breast Cancer

Prostate Cancer

Kidney Cancer

Others

Regional scope- North America; Europe; Asia Pacific; Central & South America; MEA

Table of Content

Chapter 1. Methodology & Sources

    1.1. Interventional Oncology Devices Market Definition

    1.2. Interventional Oncology Devices Market Research Scope

    1.3. Interventional Oncology Devices Market Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Interventional Oncology Devices Market Segmentation & Impact Analysis

    4.1. Interventional Oncology Devices Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

                    4.2.2.1. Increasing demand for emission-free commercial vehicles

                    4.2.2.2. Government support for Interventional Oncology Devicess

          4.2.3. Market restraints analysis

                    4.2.3.1. High development cost

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Continued…